A first-in-human study of DS-1040, an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor, in healthy subjects.
about
A first-in-human study of DS-1040, an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor, in healthy subjects.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A first-in-human study of DS-1 ...... nhibitor, in healthy subjects.
@en
A first-in-human study of DS-1 ...... nhibitor, in healthy subjects.
@nl
type
label
A first-in-human study of DS-1 ...... nhibitor, in healthy subjects.
@en
A first-in-human study of DS-1 ...... nhibitor, in healthy subjects.
@nl
prefLabel
A first-in-human study of DS-1 ...... nhibitor, in healthy subjects.
@en
A first-in-human study of DS-1 ...... nhibitor, in healthy subjects.
@nl
P2093
P2860
P356
P1476
A first-in-human study of DS-1 ...... nhibitor, in healthy subjects.
@en
P2093
Y Orihashi
P2860
P304
P356
10.1111/JTH.13658
P577
2017-02-17T00:00:00Z